Genmab A/S
GMAB
$19.93
-$0.325-1.61%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 78.55% | 13.42% | 24.66% | 10.46% | -16.70% |
| Total Depreciation and Amortization | 39.24% | -9.17% | 0.25% | 40.56% | 43.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -79.13% | 51.24% | -10.94% | 126.45% | 2,891.40% |
| Change in Net Operating Assets | -155.74% | -1,142.39% | -40.57% | -242.48% | 177.02% |
| Cash from Operations | 5.34% | 11.07% | 14.86% | -11.00% | 95.35% |
| Capital Expenditure | 49.18% | 60.32% | 42.29% | 17.08% | -19.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 372.16% | 442.53% | 196.75% | -47.25% | 61.25% |
| Cash from Investing | -666.83% | -964.85% | -192.56% | -35.96% | 52.03% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 34.07% | 7.61% | 9.68% | -20.51% | -24.66% |
| Issuance of Common Stock | -15.13% | -59.16% | -64.47% | -39.73% | -45.71% |
| Repurchase of Common Stock | -497.90% | -493.15% | -169.00% | 56.59% | 33.03% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -549.85% | -763.44% | -237.97% | 54.24% | 20.12% |
| Foreign Exchange rate Adjustments | 302.78% | 61.39% | 104.80% | -69.59% | -187.82% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -200.15% | -300.29% | -734.12% | -24.80% | 440.37% |
